The Progession Landscape of Diagnostic and Treatment Options for Kidney Cancer

Urol Clin North Am. 2023 May;50(2):xv-xvi. doi: 10.1016/j.ucl.2023.02.002.

Authors

Steven L Chang¹, Michael L Blute²

Affiliations

¹ Harvard Medical School, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Division of Urology, 45 Francis Street, Boston, MA 02115, USA. Electronic address: slchang@bwh.harvard.edu.
² Harvard Medical School, Department of Urology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: mblute@mgh.harvard.edu.

PMID: 36948678
DOI: 10.1016/j.ucl.2023.02.002

No abstract available

Publication types

Editorial

MeSH terms

Carcinoma, Renal Cell* / diagnosis
Carcinoma, Renal Cell* / therapy
Humans
Kidney Neoplasms* / diagnosis
Kidney Neoplasms* / therapy